• 1. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoindoles and derivatives Isoindolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Isoindoles and derivatives Isoindolines Isoindolones

1H-Isoindol-1-one, 2-(3,4-Dimethoxyphenyl)-2,3-Dihydro (CAS No. 89313-73-5): A Promising Scaffold in Chemical Biology and Drug Discovery

1H-Isoindol-1-one, 2-(3,4-dimethoxyphenyl)-2,3-dihydro (referred to as compound 89313-73-5) is a structurally unique organic molecule belonging to the isoindoline class of heterocyclic compounds. Its chemical formula is C₁₆H₁₆O₄, featuring a fused benzene ring with a dimethoxyphenyl substituent at position 2 and a dihydroisoindolone core. This compound has garnered significant attention in recent years due to its versatile pharmacophoric properties and emerging roles in targeting biological systems. The presence of the dimethoxyphenyl group imparts lipophilicity and potential interactions with protein binding pockets, while the isoindolone moiety contributes to hydrogen bonding capacity and redox activity.

In terms of synthetic accessibility, compound 89313-73-5 can be prepared via multistep organic synthesis involving the coupling of substituted phenols with isoquinoline derivatives. Recent advancements in asymmetric catalysis have enabled enantioselective routes for this molecule, enhancing its utility in stereochemically controlled drug design. A study published in Journal of Medicinal Chemistry (2022) demonstrated that substituent variations on the phenyl ring significantly modulate cellular uptake kinetics, suggesting its potential as a platform for structure-based optimization.

Biological evaluation reveals intriguing activities: preliminary assays indicate moderate inhibition of kinases involved in cancer signaling pathways. Notably, researchers from Stanford University (Nature Communications 2023) identified this compound as a selective inhibitor of histone deacetylase 6 (HDAC6), which plays a critical role in neurodegenerative disease progression. The dimethoxyphenyl substituent was found to enhance blood-brain barrier permeability compared to monomethylated analogs through computational docking studies.

In pharmaceutical applications, compound 89313-73-5 exhibits favorable physicochemical properties according to ADMET predictions. Its logP value of 4.8 places it within optimal hydrophobicity ranges for drug-like molecules, while microsomal stability data suggests prolonged half-life under physiological conditions. These attributes align with current trends emphasizing bioavailability and metabolic stability in early-stage drug discovery programs.

Structural analysis using X-ray crystallography confirms the presence of an intramolecular hydrogen bond between the carbonyl oxygen and nitrogen atom within the isoindolone ring, stabilizing the planar conformation essential for receptor binding. This structural feature was leveraged by a team at MIT (ACS Medicinal Chemistry Letters 2024) to develop fluorescent probes for real-time monitoring of HDAC enzyme activity in live cells using F?rster resonance energy transfer (FRET) mechanisms.

Clinical relevance studies are progressing rapidly: preclinical trials using murine models of Alzheimer's disease showed dose-dependent improvements in synaptic plasticity markers without observable hepatotoxicity at submicromolar concentrations. The compound's ability to cross the blood-brain barrier was validated through ¹⁴C radiolabeling experiments conducted by Pfizer researchers (Neuropharmacology 2024), highlighting its translational potential compared to earlier generation HDAC inhibitors.

Spectroscopic characterization confirms characteristic absorption peaks at 275 nm (UV-vis) and distinct aromatic signals between δ 6.8–7.5 ppm in ¹H NMR spectra due to the conjugated system formed by the dimethoxyphenyl group and isoindoline core. Mass spectrometry data shows molecular ion peaks at m/z 284 [M+H]⁺, aligning with theoretical calculations based on its molecular formula C₁₆H₁₆O₄.

Mechanistic studies reveal dual modes of action: besides HDAC inhibition, this compound induces autophagy flux through mTOR pathway modulation as shown by Seahorse metabolic assays (Cell Chemical Biology 2024). This pleiotropy may address limitations observed with single-target inhibitors by providing synergistic therapeutic effects against neuroinflammation and protein aggregation pathologies.

Safety evaluations conducted under OECD guidelines demonstrated no mutagenic effects up to 5 mg/mL concentrations using Ames test protocols. Acute toxicity studies in zebrafish embryos showed normal developmental patterns at IC₅₀-equivalent doses, suggesting improved safety profiles over structurally similar compounds lacking the methoxy substitutions.

The structural flexibility conferred by the partially saturated dihydroisoindolone ring enables conformational switching upon ligand binding events. Molecular dynamics simulations over 50 ns trajectories revealed dynamic interactions with both hydrophobic pockets and polar residues on target proteins - a property exploited by Merck chemists (Journal of Biological Chemistry 2024) when designing allosteric modulators for GABA receptor subtypes.

Innovative applications are emerging beyond traditional drug discovery: this molecule serves as an effective chromophore in bioorthogonal labeling strategies when conjugated with click chemistry handles such as azides or alkynes. A recent methodology report from Scripps Research Institute (JACS Au, 2024) showcased its use as a fluorescent tag for tracking intracellular protein trafficking without disrupting native interactions.

Synthesis scalability has been optimized through continuous flow chemistry approaches - University of Tokyo researchers reported kilogram-scale production yields exceeding 85% using microwave-assisted conditions combined with real-time process analytical technology (PAT). This advancement addresses previous challenges related to purification steps involving chiral resolution processes.

Bioactivity comparisons against reference compounds demonstrate superior selectivity indices across multiple assays: while traditional HDAC inhibitors like Vorinostat exhibit off-target effects on class I HDACs at therapeutic concentrations (~IC₅₀= μM range), compound 89313-73-5 maintains selectivity for HDAC6 even at nanomolar concentrations due to its unique π-stacking interactions mediated by the dimethoxyphenyl substituent.

Xenograft tumor models have provided preliminary evidence supporting its anticancer potential: when co-administered with temozolomide in glioblastoma studies published in Cancer Research, it demonstrated enhanced therapeutic efficacy via upregulation of heat shock protein pathways that counteract chemotherapy resistance mechanisms.

The compound's photophysical properties are particularly advantageous for imaging applications - femtosecond transient absorption spectroscopy revealed picosecond excited state lifetimes ideal for two-photon microscopy techniques without significant photoxicity observed up to λ=900 nm excitation wavelengths according to data from ETH Zurich (Nano Letters, Q4/20).

New mechanistic insights from cryo-electron microscopy studies published late last year reveal how the isoindole core binds within enzyme active sites through dual hydrogen bonds involving both carbonyl oxygen atoms - this "double anchor" interaction provides enhanced binding affinity compared to single-bonded analogs previously reported in literature databases such as PubChem CID: ... .

In vivo pharmacokinetic profiles show linear dose-response relationships up to mg/kg dosing levels when formulated into lipid-based nanoparticles - University College London trials achieved brain tissue accumulation rates exceeding 7% ID/g after intravenous administration using radiotracer techniques...

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)